## CCEP: Coca-Cola Europacific Partners  - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%); PEG 1.48 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($89.06)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Precision Trading with Coca-cola Europacific Partners Plc Euro Shs (CCEP) Risk Zones**
- Source: Stock Traders Daily | 20251219T113200 | Bullish | Relevance: 100%
- This article provides a precision trading analysis for Coca-Cola Europacific Partners Plc Euro Shs (CCEP), highlighting strong near-term sentiment with a long-term positive bias. It presents three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis and specific entry/target/stop-loss zones. The report emphasizes an exceptional 21.3:1 risk-reward short setup.

**2. REG - Coca-Cola EP PLC - Directorate Change**
- Source: TradingView — Track All Markets | 20251218T160925 | Neutral | Relevance: 100%
- Coca-Cola Europacific Partners plc (CCEP) announced a directorate change involving the retirement of Thomas Johnson, an Independent Non-Executive Director and Senior Independent Director, effective May 28, 2026. Laurence Debroux will be appointed as an Independent Non-Executive Director, also effective May 28, 2026, bringing extensive experience in finance and international corporate leadership to the Board. This change is part of the Board's succession planning to ensure continued strong governance.

**3. Directorate Change**
- Source: Actusnews | 20251218T200911 | Somewhat-Bullish | Relevance: 100%
- Coca-Cola Europacific Partners plc (CCEP) announces the retirement of Thomas Johnson, an Independent Non-Executive Director and Senior Independent Director, effective May 28, 2026. Concurrently, Laurence Debroux has been appointed as an Independent Non-Executive Director, also effective from the 2026 Annual General Meeting. This appointment is part of the Board's succession planning, ensuring continued strong leadership and governance for CCEP.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 16.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Invesco Ltd.: 3.5% (+31.6%)
- Blackrock Inc.: 3.4% (-1.3%)
- Vanguard Group Inc: 2.4% (+2.6%)
- Goldman Sachs Group : 1.5% (+6.9%)
- Boston Partners: 1.4% (+2.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.48 suggests fair value with growth premium. Forward P/E 20.7x stretched relative to 9% growth. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.4B |
| Beta | 0.38 |
| 52W Range | $73.40 - $100.67 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.48 |
| Forward P/E | 20.7 |
| Current P/E | 22.5 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.1% to 1.1% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.10% (CS: 72) | Neutral |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.020x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $92.14
- **Stop Loss:** $89.06 (3.3% risk)
- **Target:** $95.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 389
- **Position Value:** $35,842.46
- **Portfolio %:** 35.84%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-17 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*